AJ Vaccines upgrades for DKK 300 million

In order to ramp up production of its new polio vaccine, AJ Vaccines has invested DKK 300 million (EUR 40 million) in upgrading existing production facilities in Copenhagen.

CEO Klaus Hermansen (to the left) and AJ Vaccines team at the signing of a partnership deal earlier this year for a new meningitis vaccine. Photo: AJ Vaccines PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

David Solomon lander nyt topjob

Mindre end tre måneder efter at være trådt tilbage som adm. direktør i amerikansk biotekselskab efter kontrovers om brug af et kreditkort er den tidligere Zealand Pharma-topchef David Solomon atter tilbage i direktørstolen. Denne gang i et britisk biotekselskab.

Related articles